Markets & Regulations

(Image: Getty/Mohd Hafiez Mohd Razali / EyeEm)

WHO indicates preferred HIV treatment

By Vassia Barba

Citing evidence from two completed clinical trials, the WHO recommends dolutegravir as the preferred treatment for all patients with HIV.

Follow us

Products

View more

Webinars